Patients received Dato-DXd 6 mg/kg once every 3 weeks. The primary end point was objective response rate (ORR) by blinded independent central review. Secondary end points included duration of response ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback